J. Schmider

1.1k total citations
17 papers, 896 citations indexed

About

J. Schmider is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Molecular Biology. According to data from OpenAlex, J. Schmider has authored 17 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in J. Schmider's work include Pharmacogenetics and Drug Metabolism (5 papers), Stress Responses and Cortisol (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). J. Schmider is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Stress Responses and Cortisol (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). J. Schmider collaborates with scholars based in Germany, United States and Denmark. J. Schmider's co-authors include Michael Dettling, U. Gotthardt, Isabella J.E. Heuser, Ulrich Schweiger, Claas-H. Lammers, C. Lammers, U. Schweiger, Alexander Yassouridis, Isabella Heuser and Richard I. Shader and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J. Schmider

17 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Schmider Germany 9 472 248 243 179 146 17 896
Tatjana Dose Germany 7 124 0.3× 177 0.7× 82 0.3× 40 0.2× 71 0.5× 10 658
B. Bondy Germany 8 143 0.3× 224 0.9× 76 0.3× 40 0.2× 99 0.7× 13 948
P A Seymour United States 10 346 0.7× 234 0.9× 114 0.5× 198 1.1× 30 0.2× 14 1.4k
F. David Tingley United States 13 327 0.7× 143 0.6× 130 0.5× 148 0.8× 29 0.2× 19 1.4k
Elżbieta Gałecka Poland 15 380 0.8× 469 1.9× 82 0.3× 49 0.3× 18 0.1× 36 939
Ilja Spellmann Germany 21 501 1.1× 707 2.9× 42 0.2× 87 0.5× 66 0.5× 36 1.7k
Shoko Tsuchimine Japan 18 96 0.2× 165 0.7× 69 0.3× 34 0.2× 79 0.5× 67 893
Gregory C. Janis United States 15 272 0.6× 59 0.2× 69 0.3× 105 0.6× 95 0.7× 29 1.3k
Silvia Paddock United States 9 153 0.3× 211 0.9× 70 0.3× 38 0.2× 70 0.5× 17 826
Pascal Barone France 12 396 0.8× 609 2.5× 33 0.1× 74 0.4× 21 0.1× 21 1.1k

Countries citing papers authored by J. Schmider

Since Specialization
Citations

This map shows the geographic impact of J. Schmider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Schmider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Schmider more than expected).

Fields of papers citing papers by J. Schmider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Schmider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Schmider. The network helps show where J. Schmider may publish in the future.

Co-authorship network of co-authors of J. Schmider

This figure shows the co-authorship network connecting the top 25 collaborators of J. Schmider. A scholar is included among the top collaborators of J. Schmider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Schmider. J. Schmider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Johne, Andreas, Elke S. Perloff, Steffen Bauer, et al.. (2004). Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers. European Journal of Clinical Pharmacology. 60(9). 617–622. 11 indexed citations
2.
Kaiser, Rolf, J. Schmider, Maren Henneken, et al.. (2001). Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Molecular Psychiatry. 6(2). 179–185. 73 indexed citations
3.
Störmer, Elke, Jürgen Brockmöller, Ivar Roots, & J. Schmider. (2000). Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro. Psychopharmacology. 151(4). 312–320. 21 indexed citations
4.
Deuschle, Michael, W. F. Blum, Jan Frystyk, et al.. (1998). Endurance Training and its Effect upon the Activity of the GH-IGFs System in the Elderly. International Journal of Sports Medicine. 19(4). 250–254. 40 indexed citations
5.
Heuser, Isabella, Garth Bissette, Michael Dettling, et al.. (1998). Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment. Depression and Anxiety. 8(2). 71–79. 175 indexed citations
6.
Schmider, J., et al.. (1997). P.3.034 A double blind comparison of lorazepam and oxazepam in psychogenic catatonia. European Neuropsychopharmacology. 7. S237–S237. 2 indexed citations
7.
Schmider, J., David J. Greenblatt, Lisa L. von Moltke, et al.. (1996). Characterization of Six in vitro Reactions Mediated by Human Cytochrome P450: Application to the Testing of Cytochrome P450-Directed Antibodies. Pharmacology. 52(2). 125–134. 41 indexed citations
8.
Moltke, Lisa L. von, David J. Greenblatt, J. Schmider, Jerold S. Harmatz, & Richard I. Shader. (1996). Nefazodone in vitro: Metabolic conversions, and inhibition of P450-3A isoforms.. Clinical Pharmacology & Therapeutics. 59(2). 176–176. 7 indexed citations
9.
Heuser, Isabella J.E., U. Schweiger, U. Gotthardt, et al.. (1996). Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. American Journal of Psychiatry. 153(1). 93–99. 222 indexed citations
10.
Schmider, J., et al.. (1996). Metabolic inhibitors of the biotransformation of mestranol to ethinylestradiol in vitro.. Clinical Pharmacology & Therapeutics. 59(2). 171–171. 1 indexed citations
11.
Schmider, J., Michael Deuschle, Ulrich Schweiger, et al.. (1995). Amitriptyline Metabolism in Elderly Depressed Patients and Normal Controls in Relation to Hypothalamic-Pituitary-Adrenal System Function. Journal of Clinical Psychopharmacology. 15(4). 250–258. 5 indexed citations
12.
Schmider, J., D J Greenblatt, Lisa L. von Moltke, J S Harmatz, & Richard I. Shader. (1995). N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 592–597. 80 indexed citations
13.
Deuschle, Michael, Werner Blum, U. Schweiger, et al.. (1995). Increased IGF-1 in patients with major depression. Biological Psychiatry. 37(9). 603–603. 2 indexed citations
14.
Schweiger, U., Michael Deuschle, Antje Körner, et al.. (1995). Insulin secretion and insulin sensitivity in major depression. Biological Psychiatry. 37(9). 603–603. 3 indexed citations
15.
Heuser, Isabella J.E., U. Gotthardt, Ulrich Schweiger, et al.. (1994). Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender. Neurobiology of Aging. 15(2). 227–231. 210 indexed citations
16.
Schweiger, U., Michael Deuschle, A. Kørner, et al.. (1994). Decreased lumbar bone mineral density in patients with major depression. Biological Psychiatry. 35(9). 730–730. 2 indexed citations
17.
Gotthardt, U., J. Schmider, Ulrich Schweiger, et al.. (1994). Blood pressure and heart rate regulation in young and elderly healthy controls in comparison to depressed patients under baseline and mental stress condition. Biological Psychiatry. 35(9). 648–648. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026